Iloprost

Overview

Iloprost is a synthetic analogue of prostacyclin, used in the treatment of pulmonary arterial hypertension. It works by dilating blood vessels and inhibiting platelet aggregation.

API suppliers (4)

Suppliers of Iloprost backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Bayer AGGermany1 active DMF
• Bayer AGGermany1 active DMF
• Bayer AGGermany1 active DMF
• SCHERING AG

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Iloprost expires 17 Jul 2044 and exclusivity 13 Feb 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas